Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
OPERATING EXPENSES
Amortization	$ 57,344	$ 57,344
Research and development expenses	100,914	341,501
Selling, general and administrative expenses	228,497	307,373
TOTAL OPERATING EXPENSES	386,755	706,218
LOSS FROM OPERATIONS	(386,755)	(706,218)
OTHER EXPENSE (INCOME)
Change in fair value of derivative liabilities	(8,279,919)	(362,586)
Interest Expense	559,312	3,477,615
Interest income	(64)	(20)
TOTAL OTHER EXPENSE (INCOME)	(7,720,671)	3,115,009
NET INCOME (LOSS)	7,333,916	(3,821,227)
Deemed dividend - Related Party	53,598,320	17,099,058
NET LOSS ATTRIBUTABLE TO COMPANY STOCKHOLDERS	$ (46,264,404)	$ (20,920,285)
NET LOSS PER COMMON SHARE, BASIC	$ (7.75)	$ (5.06)
NET LOSS PER COMMON SHARE, DILUTED	$ (7.75)	$ (5.06)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC	5,971,622	4,132,617
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, DILUTED	5,971,622	4,132,617